Search research articles
Contact Us
Filters
Showing results (61-70 of 140) with videos related to
Page
of 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 1997
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden
F Nolè, F de Braud, M Aapro, et al.
British Journal of Cancer
|
December 9, 2003
Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations
R Stahel, A Rossi, L Petruzelka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas
T De Pas, G Curigliano, G Masci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2005
Reply to the article "Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity" by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543-1550): ... and in humans?
T De Pas, M Colleoni, L Orlando, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors
N Zilembo, R Buzzoni, E Bajetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A D Roth, R Maibach, N Fazio, et al.
British Journal of Cancer
|
July 27, 2006
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
V Mey, E Giovannetti, F De Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 1998
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study
E Díaz-Rubio, J Sastre, A Zaniboni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 12, 2005
Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain
T De Pas, A Sbanotto, C Catania, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
L Orlando, M Colleoni, F Nolè, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 140) with videos related to
Sort By:
Page
of 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 1997
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden
F Nolè, F de Braud, M Aapro, et al.
British Journal of Cancer
|
December 9, 2003
Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations
R Stahel, A Rossi, L Petruzelka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas
T De Pas, G Curigliano, G Masci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2005
Reply to the article "Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity" by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543-1550): ... and in humans?
T De Pas, M Colleoni, L Orlando, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors
N Zilembo, R Buzzoni, E Bajetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A D Roth, R Maibach, N Fazio, et al.
British Journal of Cancer
|
July 27, 2006
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
V Mey, E Giovannetti, F De Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 1998
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study
E Díaz-Rubio, J Sastre, A Zaniboni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 12, 2005
Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain
T De Pas, A Sbanotto, C Catania, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
L Orlando, M Colleoni, F Nolè, et al.
Page
of 14